Legal & General Group PLC Nektar Therapeutics Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Legal & General Group PLC holds 15,399 shares of NKTR stock, worth $16,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,399

Previous 15,399 -0.0%

Holding current value

$16,476

Previous $20,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.9 - $1.83 $13,859 - $28,180	15,399 New	15,399 $19,000
Q1 2023 May 15, 2023	SELL	$0.64 - $3.15 $83,902 - $412,955	-131,097 Reduced 24.21%	410,332 $287,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $4.28 $28,799 - $60,720	14,187 Added 2.69%	541,429 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $284,249 - $480,605	-93,503 Reduced 15.06%	527,242 $1.69 Million
Q2 2022 Aug 22, 2022	BUY	$3.17 - $6.17 $4,520 - $8,798	1,426 Added 0.23%	620,745 $2.36 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $435,864 - $1.44 Million	104,775 Added 20.36%	619,319 $3.34 Million
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $2.86 Million - $4.85 Million	263,708 Added 105.13%	514,544 $6.95 Million
Q3 2021 Nov 15, 2021	BUY	$13.07 - $18.84 $443,569 - $639,391	33,938 Added 15.65%	250,836 $4.51 Million
Q2 2021 Aug 12, 2021	SELL	$16.52 - $20.4 $790,812 - $976,547	-47,870 Reduced 18.08%	216,898 $3.72 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $619,625 - $952,636	-37,417 Reduced 12.38%	264,768 $5.3 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $365,185 - $440,677	-23,157 Reduced 7.12%	302,185 $5.14 Million
Q3 2020 Nov 13, 2020	BUY	$16.59 - $24.79 $330,721 - $494,188	19,935 Added 6.53%	325,342 $5.4 Million
Q2 2020 Aug 14, 2020	SELL	$16.86 - $23.44 $421,533 - $586,046	-25,002 Reduced 7.57%	305,407 $7.07 Million
Q1 2020 May 14, 2020	BUY	$14.47 - $27.96 $345,123 - $666,873	23,851 Added 7.78%	330,409 $5.93 Million
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $6.06 Million - $8.83 Million	-381,806 Reduced 55.47%	306,558 $6.61 Million
Q3 2019 Nov 13, 2019	BUY	$16.91 - $36.27 $321,103 - $688,731	18,989 Added 2.84%	688,364 $12.5 Million
Q2 2019 Aug 14, 2019	BUY	$31.0 - $36.3 $1.53 Million - $1.79 Million	49,373 Added 7.96%	669,375 $23.8 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $6.73 Million - $9.88 Million	213,092 Added 52.37%	620,002 $20.8 Million
Q4 2018 Feb 15, 2019	BUY	$30.43 - $56.65 $1.72 Million - $3.2 Million	56,553 Added 16.14%	406,910 $13.4 Million
Q3 2018 Nov 20, 2018	BUY	$46.46 - $68.49 $2.13 Million - $3.14 Million	45,885 Added 15.07%	350,357 $21.3 Million
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $7.09 Million - $16 Million	153,270 Added 101.37%	304,472 $14.8 Million
Q1 2018 May 17, 2018	SELL	$57.4 - $108.44 $9.41 Million - $17.8 Million	-163,865 Reduced 52.01%	151,202 $16.1 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $7.25 Million - $19.1 Million	315,067	315,067 $18.8 Million

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Nektar Therapeutics Transaction History